These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31111534)

  • 1. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.
    Wang J; Li X; Wu H; Wang H; Yao L; Deng Z; Zhou Y
    J Cell Biochem; 2019 Oct; 120(10):17142-17150. PubMed ID: 31111534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
    Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
    Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway.
    Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX
    J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
    Zhang A; Peng S; Sun S; Ye S; Zhao Y; Wu Q
    Cancer Med; 2024 Aug; 13(16):e70100. PubMed ID: 39149873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Girdin regulates the migration and invasion of glioma cells via the PI3K-Akt signaling pathway.
    Ni W; Fang Y; Tong L; Tong Z; Yi F; Qiu J; Wang R; Tong X
    Mol Med Rep; 2015 Oct; 12(4):5086-92. PubMed ID: 26151295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
    Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIF3C Promotes Proliferation, Migration, and Invasion of Glioma Cells by Activating the PI3K/AKT Pathway and Inducing EMT.
    Gao Y; Zheng H; Li L; Zhou C; Chen X; Zhou X; Cao Y
    Biomed Res Int; 2020; 2020():6349312. PubMed ID: 33150178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells.
    Sun S; Xue D; Chen Z; Ou-Yang Y; Zhang J; Mai J; Gu J; Lu W; Liu X; Liu W; Sheng L; Lu B; Lin Y; Xing F; Chen Z; Mou Y; Yan G; Zhu W; Sai K
    Cell Death Dis; 2019 May; 10(5):358. PubMed ID: 31043589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
    Guo SK; Shen MF; Yao HW; Liu YS
    Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.
    Peng R; Jiang B; Ma J; Ma Z; Wan X; Liu H; Chen Z; Cheng Q; Chen R
    Oncol Rep; 2013 Nov; 30(5):2195-202. PubMed ID: 24008630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma.
    Chen J; Zhang J; Hong L; Zhou Y
    Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.